AN1
Click for more information
0.00% 0.8¢ anagenics limited

cancer diagnosis, page-20

  1. bluemoon
    78 Posts.
    clock Created with Sketch.
    03/11/10
    15:32
    Post #: 7424259
    Quoting from the announcement!

    Cellmids reliable and reproducible MK ELISA is essential for the validation of cancer
    diagnostic and prognostic applications. It will also enable the wider scientific
    community engaged in midkine research to confidently generate data for
    diagnostic and therapeutic applications.

    IMHO That alone is exciting news!
    CDY Price at posting: 4.4¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS High-grade manganese found at the W2 prospect in Wandanya
right-arrow Created with Sketch.
NEWS $140,000 in grant funding has been secured for drilling at Golden Ridge, with preparations underway for two exciting prospects
right-arrow Created with Sketch.
NEWS Uncover the potential at the Storm Project, where exceptional RC drill results reveal 22.9m at 8.5% Cu, indicating significant resource expansion beyond the Cyclone Deposit
right-arrow Created with Sketch.
NEWS Nine-month toxicology study completed, find out which biotech just made a breakthrough
right-arrow Created with Sketch.
NEWS Kathleen Valley’s first spodumene shipment departs—see how this company is advancing fast
right-arrow Created with Sketch.
NEWS New gold-copper assays boost confidence in major porphyry target—discover the potential
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.690M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.